Vasile Musteata

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Escherichia Coli

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Top Venues

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Andrés Gómez-De León, Andrés Noyola-Pérez, Lourdes Gil-Flores, Hemant Malhotra, Vasile Musteata, Amal Mohamed El-Beshlawy, Hilman Tadjoedin, Carolina Pavlovsky, Jorge E Cortes
Bringing global hematology research to the forefront. Blood advances 8 (14) (2024)
Andrés Gómez-De León, Andrés Noyola-Pérez, Lourdes Gil-Flores, Hemant Malhotra, Vasile Musteata, Amal Mohamed El-Beshlawy, Hilman Tadjoedin, Carolina Pavlovsky, Jorge E Cortes
Bringing global hematology research to the forefront. Blood advances 8 (14) (2024)
Andrés Gómez-De León, Andrés Noyola-Pérez, Lourdes Gil-Flores, Hemant Malhotra, Vasile Musteata, Amal Mohamed El-Beshlawy, Hilman Tadjoedin, Carolina Pavlovsky, Jorge E Cortes
Bringing global hematology research to the forefront. Blood advances 8 (14) (2024)
Andrés Gómez-De León, Andres Noyola-Pérez, Lourdes Gil-Flores, Hemant Malhotra, Vasile Musteata, Amal Mohamed El-Beshlawy, Hilman Tadjoedin, Carolina Pavlovsky, Jorge E Cortes
Bringing Global Hematology Research to the Forefront. Blood advances (2024)
Paul A Hamlin, Vasile Musteata, Steven I Park, Christine Burnett, Kristina Dabovic, Thomas Strack, Eric T Williams, Banmeet S Anand, Jack P Higgins, Daniel O Persky
Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma. Cancer research communications 2 (5) (2022)
Paul A Hamlin, Vasile Musteata, Steven I Park, Christine Burnett, Kristina Dabovic, Thomas Strack, Eric T Williams, Banmeet S Anand, Jack P Higgins, Daniel O Persky
Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma. Cancer research communications 2 (5) (2022)